116 related articles for article (PubMed ID: 38562210)
1. The Potential of FOXP3 in Predicting Survival and Treatment Response in Breast Cancer.
Liu L; Xiao W; Zhang C; Fan P; Zeng J; Yi J
Int J Gen Med; 2024; 17():1233-1251. PubMed ID: 38562210
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of Prognostic and immune infiltrates for FOXPs Transcription Factors in Human Breast Cancer.
Yi J; Tan S; Zeng Y; Zou L; Zeng J; Zhang C; Liu L; Fan P
Sci Rep; 2022 May; 12(1):8896. PubMed ID: 35614183
[TBL] [Abstract][Full Text] [Related]
3. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
4. The expression landscape of FOXP3 and its prognostic value in breast cancer.
Li J; Zhang X; Liu B; Shi C; Ma X; Ren S; Zhao X; Liu Y
Ann Transl Med; 2022 Jul; 10(14):801. PubMed ID: 35965804
[TBL] [Abstract][Full Text] [Related]
5. Radiomics Features on Enhanced Computed Tomography Predict FOXP3 Expression and Clinical Prognosis in Patients with Head and Neck Squamous Cell Carcinoma.
Wang Y; Ye J; Zhou K; Chen N; Huang G; Feng G; Zhang G; Gou X
J Imaging Inform Med; 2024 Feb; ():. PubMed ID: 38376584
[TBL] [Abstract][Full Text] [Related]
6. Integrating Bioinformatics and Drug Sensitivity Analyses to Identify Molecular Characteristics Associated with Targeting Necroptosis in Breast Cancer and their Clinical Prognostic Significance.
Zheng C; Guo H; Mo Y; Liu G
Recent Pat Anticancer Drug Discov; 2023 Aug; ():. PubMed ID: 37653627
[TBL] [Abstract][Full Text] [Related]
7. Elevated mRNA Level of Y-Box Binding Protein 1 Indicates Unfavorable Prognosis Correlated with Macrophage Infiltration and T Cell Exhaustion in Luminal Breast Cancer.
Lv Z; Xue C; Zhang L; Sun J; Bo C
Cancer Manag Res; 2021; 13():6411-6428. PubMed ID: 34429650
[TBL] [Abstract][Full Text] [Related]
8. Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer.
Song C; Shang F; Tu W; Liu X
BMC Cancer; 2023 Mar; 23(1):296. PubMed ID: 37004015
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Analysis of the Associations of LOXL1-4 with Prognosis and Immune Infiltration in Breast Cancer.
He L; Lin Y; Huang P; Pan H
Altern Ther Health Med; 2024 Mar; ():. PubMed ID: 38518152
[TBL] [Abstract][Full Text] [Related]
10. Synergistic association of FOXP3+ tumor infiltrating lymphocytes with CCL20 expressions with poor prognosis of primary breast cancer: A retrospective cohort study.
Zhao X; Li Y; Wang X; Wu J; Yuan Y; Lv S; Ren J
Medicine (Baltimore); 2019 Dec; 98(50):e18403. PubMed ID: 31852159
[TBL] [Abstract][Full Text] [Related]
11. FN1 overexpression is correlated with unfavorable prognosis and immune infiltrates in breast cancer.
Zhang XX; Luo JH; Wu LQ
Front Genet; 2022; 13():913659. PubMed ID: 36035176
[No Abstract] [Full Text] [Related]
12. Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer.
Jørgensen N; Hviid TVF; Nielsen LB; Sønderstrup IMH; Eriksen JO; Ejlertsen B; Gerdes AM; Kruse TA; Thomassen M; Jensen MB; Lænkholm AV
Br J Cancer; 2021 Nov; 125(10):1388-1398. PubMed ID: 34365471
[TBL] [Abstract][Full Text] [Related]
13. Performance of a PLK1-based immune risk model for prognosis and treatment response prediction in breast cancer.
Chen Y; You Y; Wu Q; Wu J; Lin S; Sun Y; Cui Z
Cancer Med; 2023 May; 12(9):11020-11039. PubMed ID: 36951624
[TBL] [Abstract][Full Text] [Related]
14. Construction of a breast cancer prognosis model based on alternative splicing and immune infiltration.
Zhang D; Lu W; Zhuo Z; Mei H; Wu X; Cui Y
Discov Oncol; 2022 Aug; 13(1):78. PubMed ID: 35988113
[TBL] [Abstract][Full Text] [Related]
15. Elucidating cuproptosis-related gene SLC31A1 diagnostic and prognostic values in cancer.
Mi J; Luo J; Zeng H; Zhang H; Jamil M; Abdel-Maksoud MA; Zakri AM; Alfuraydi AA; Zhang N; Xiao M
Am J Transl Res; 2023; 15(10):6026-6041. PubMed ID: 37969191
[TBL] [Abstract][Full Text] [Related]
16. Ceruloplasmin correlates with immune infiltration and serves as a prognostic biomarker in breast cancer.
Chen F; Han B; Meng Y; Han Y; Liu B; Zhang B; Chang Y; Cao P; Fan Y; Tan K
Aging (Albany NY); 2021 Aug; 13(16):20438-20467. PubMed ID: 34413268
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
[TBL] [Abstract][Full Text] [Related]
18. Polo-like kinase 1 as a biomarker predicts the prognosis and immunotherapy of breast invasive carcinoma patients.
Shen J; Zhang W; Jin Q; Gong F; Zhang H; Xu H; Li J; Yao H; Jiang X; Yang Y; Hong L; Mei J; Song Y; Zhou S
Oncol Res; 2023; 32(2):339-351. PubMed ID: 38186570
[TBL] [Abstract][Full Text] [Related]
19. ACE2 maybe serve as a prognostic biomarker in breast invasive carcinoma.
Ling J; Peng N; Luo L
J Clin Lab Anal; 2022 Jun; 36(6):e24362. PubMed ID: 35373393
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration.
Liu S; Foulkes WD; Leung S; Gao D; Lau S; Kos Z; Nielsen TO
Breast Cancer Res; 2014 Sep; 16(5):432. PubMed ID: 25193543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
